STRATA CRITICAL MEDICAL, INC. Debt Securities, Available-for-sale, Amortized Cost
STRATA CRITICAL MEDICAL, INC. (SRTA) had Debt Securities, Available-for-sale, Amortized Cost of $268.70 million as of 2022-03-31, per its 10-Q filed 2022-05-10.
Discontinued › Notes › Debt Securities, Available-for-Sale, Amortized Cost
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2023-01-10
- 2022-03-31: Debt Securities, Available-for-sale, Amortized Cost $268.70M.
- 2021-12-31: Debt Securities, Available-for-sale, Amortized Cost $280.26M.
- 2021-09-30: Debt Securities, Available-for-sale, Amortized Cost $297.47M.
- 2020-09-30: Debt Securities, Available-for-sale, Amortized Cost $0.00.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2022-03-31 | $268.70M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $280.26M 8-K · filed 2023-01-10 |
| 2021-09-30 | $297.47M 8-K · filed 2023-01-10 |
| 2020-09-30 | $0.00 10-K · filed 2021-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |